ISSN: 0145-2126
Journal Home
Journal Guideline
Leukemia Research Q2 Unclaimed
Leukemia Research is a journal indexed in SJR in Hematology and Oncology with an H index of 96. It has an SJR impact factor of 0,694 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,694.
Leukemia Research focuses its scope in these topics and keywords: leukemia, induces, myeloid, monoclonal, antibody, apoptosis, inhibition, patients, chronic, tcells, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,694
SJR Impact factor96
H Index123
Total Docs (Last Year)405
Total Docs (3 years)3859
Total Refs707
Total Cites (3 years)281
Citable Docs (3 years)1.61
Cites/Doc (2 years)31.37
Ref/DocOther journals with similar parameters
Cytokine: X Q2
Cytokine Q2
Hematological Oncology Q2
Platelets Q2
Stem Cells and Development Q2
Compare this journals
Aims and Scope
Best articles by citations
Younger age observation IN myelodysplastic syndrome
View moreTranslocation (8;21) in acute myeloid leukemia: When to treat? That is the question!!
View morep53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: impact of antibody selection
View moreSezary cells with hairy projections
View more121 Myelodysplastic syndrome and 17P deletion
View moreA comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations
View more76 The absolute number of CD34+ cells and CD34+ cells in S-phase increase during the evolution of myelodysplastic syndromes (MDS)
View more125 Clonal karyotypic abnormalities after autologous transplantation (AT)
View more163 Amifostine in low-risk and combined therapy with gemcitabine in high-risk myelodysplastic syndromes
View more50 Correlation of karyotype with clinical features and prognosis in 349 patients with MDS
View more127 Both inhaled and ingested substances are involved in secondary myelodysplastic syndromes (MDS) with 6p changes
View more128 Single del(11q) in a patient with RAEB which progressed to erythroleukemia
View more169 Aggressive chemotherapy in MDS: The Dusseldorf experience
View more26 Cytoplasmic abnormalities of erythroblasts in a patient with refractory anaemia with ring sideroblasts
View more8 The history of MDS: The role of the F.A.B. classification and the development of risk assessment
View moreDeletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia
View moreTobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case-control study in Uruguay
View moreKRN5500 induces apoptosis (PCD) of myeloid leukemia cell lines and patient blasts
View moreThe MRD1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes
View moreAutocrine and possible intracrine regulation of HL-60 cell proliferation by macrophage colony-stimulating factor
View more45 Myelodysplastic syndrome in its fibrotic variant: A borderline to chronic myeloproliferation
View moreSuccessful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome
View moreAutocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines
View more132 A case of a t(1;3)(p36:q21) in chronic myelomonocytic leukemia with thrombocytosis and TPO gene expression in malignant cells
View more
Comments